Bloomberg Anywhere Remote Login Bloomberg Terminal Demo Request


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

October 04, 2015 5:30 PM ET


Company Overview of Chiesi USA, Inc.

Company Overview

Chiesi USA, Inc., a specialty pharmaceutical company, engages in the acquisition, development, and commercialization of prescription pharmaceutical drugs for the hospital and adjacent specialty markets. The company offers CARDENE I.V., a premixed injection for the short-term treatment of hypertension; CUROSURF, a natural lung surfactant for the treatment of respiratory distress syndrome in premature infants; and ZYFLO, a leukotriene synthesis inhibitor for prophylaxis and chronic treatment of asthma in adults and children 12 years of age and older. It also provides BETHKIS, an inhaled tobramycin-based product for the management of cystic fibrosis patients with pseudomonas aeruginosa; and hyd...

1255 Crescent Green Drive

Suite 250

Cary, NC 27518

United States

105 Employees





Key Executives for Chiesi USA, Inc.

Chairman and Chief Executive Officer
Age: 49
Age: 50
Chief Financial Officer and Vice President of Finance
Principal Accounting Officer and Director of Accounting, Financial Planning & Analysis
Vice President of Clinical and Regulatory
Age: 52
Compensation as of Fiscal Year 2015.

Chiesi USA, Inc. Key Developments

Chiesi USA, Inc. Presents at 7th annual Biotech Showcase Conference 2015, Jan-12-2015

Chiesi USA, Inc. Presents at 7th annual Biotech Showcase Conference 2015, Jan-12-2015 . Venue: Parc 55 Wyndham San, Francisco - Union Square, San Francisco, CA 94102, United States.

Chiesi USA, Inc. Presents at EBD Group's Biopharm America 2014 Conference, Sep-22-2014

Chiesi USA, Inc. Presents at EBD Group's Biopharm America 2014 Conference, Sep-22-2014 . Venue: Boston Marriott Copley Place, 110 Huntington Avenue, Boston, MA 02116, United States.

Cornerstone Therapeutics Inc. has Changed its Name to Chiesi USA, Inc

On April 28, 2014, Cornerstone Therapeutics Inc. changed its name to Chiesi USA, Inc.

Similar Private Companies By Industry

Company Name Region
AlexiPharma, Inc. United States
Centella Therapeutics, Inc. United States
pHase Pharmaceuticals, LLC United States
Boehringer Ingelheim Pharmaceuticals, Inc. United States
Recovery Pharmaceuticals, Inc. United States

Recent Private Companies Transactions

No transactions available in the past 12 months.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
NYC2012, Inc. United States
Bertelsmann AG Europe
Rush University United States
Citizens Budget Commission United States

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Chiesi USA, Inc., please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at